SWOG Cancer Research Network: Breast Neoplasms trials

The registry lists 44 Breast Neoplasms studies with SWOG Cancer Research Network as lead sponsor. 2 are open to participants now and 16 have results posted.

Phase 1 1Phase 2 9Phase 3 20No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Adding Capivasertib to Standard Treatment in HR Positive, HER2 Negative Metastatic Breast Cancer Based on ctDNA TestingNot yet recruitingNCT07802626Phase 3
• S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityRecruitingNCT03418961Phase 3
• S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)CompletedNCT02728596Not applicableResults posted
• S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast CancerTerminatedNCT02137837Phase 3Results posted
• S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerActive, not recruitingNCT01674140Phase 3Results posted
• S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone TherapyCompletedNCT01598298Phase 3Results posted
• S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone ThpyCompletedNCT01385137Phase 3Results posted
• S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast CancerCompletedNCT00856492Phase 2Results posted
• S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing ChemoCompletedNCT00775645Phase 3Results posted
• S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the BoneCompletedNCT00410813Phase 2Results posted
• S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With ChemoCompletedNCT00382018Phase 3Results posted
• S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.CompletedNCT00127205Phase 3Results posted
• S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast CancerCompletedNCT00107276Phase 2Results posted
• S0300, Celecoxib in Preventing Breast Cancer in Premenopausal WomenTerminatedNCT00088972Phase 2Results posted
• S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast CancerCompletedNCT00075764Phase 3Results posted
• S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast CancerActive, not recruitingNCT00070564Phase 3Results posted
• S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast CancerCompletedNCT00068601Phase 3Results posted
• S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast CancerCompletedNCT00041067Phase 2Results posted
• S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast CancerCompletedNCT01535066Not applicable
• S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast CancerCompletedNCT01515800Not applicable
• S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer SurvivorsCompletedNCT01453452Not applicable
• S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast CancerCompletedNCT01097278Not applicable
• S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313CompletedNCT00949013
• S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid TumorsWithdrawnNCT00937417Phase 1
• SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast CancerCompletedNCT00929591Phase 3
• S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and FluorouracilCompletedNCT00897091
• S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313CompletedNCT00896727
• SWOG 8897-A DNA Analysis in Predicting Treatment Outcome in Women With Breast Cancer in SWOG 8897CompletedNCT00896623
• S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesCompletedNCT00874211
• S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307WithdrawnNCT00873808
• S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the BoneWithdrawnNCT00301886Phase 3
• S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in RemissionWithdrawnNCT00227474Phase 2
• S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast CancerWithdrawnNCT00217659Phase 2
• Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast CancerCompletedNCT00103233Phase 3
• S9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast CancerCompletedNCT00031772Not applicable
• S0029 Docetaxel in Treating Older Women With Metastatic Breast CancerTerminatedNCT00025493Phase 2
• S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast CancerCompletedNCT00016406Phase 3
• S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast CancerCompletedNCT00015938Phase 2
• S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast CancerTerminatedNCT00005983Phase 3
• S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast CancerCompletedNCT00005975Phase 3
• S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast CancerCompletedNCT00003095
• S9630, Medroxyprogesterone in Treating Women With Breast CancerCompletedNCT00002920Phase 3
• SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical TrialCompletedNCT00002900
• S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast CancerTerminatedNCT00002772Phase 3